학술논문
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)
Document Type
Article
Author
Source
In Gynecologic Oncology January 2020 156(1):45-53
Subject
Language
ISSN
0090-8258